Informations sur le produit
Epitinib succinate is a potent and selective inhibitor of human epidermal growth factor receptor (EGFR) tyrosine kinase, which is overexpressed in many types of cancer. This Chinese analog of the anticancer drug Gefitinib has been shown to inhibit tumor growth and induce apoptosis in cancer cells. Epitinib succinate selectively inhibits EGFR kinases by binding to the ATP-binding site, leading to inhibition of downstream signaling pathways that promote cell proliferation and survival. This drug has been tested in preclinical studies and has shown promising results as a potential treatment for various types of cancer. Epitinib succinate can be detected in urine and is currently being investigated as a potential toxin for targeted cancer therapy.
Propriétés chimiques
Question d’ordre technique sur : 3D-CQD33412 Epitinib succinate
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
